Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00763152 · ClinicalTrials.gov registry record
CMT-07-08: The PROstate Bed Evaluation Study
A clinical trial, sponsored by Varian, a Siemens Healthineers Company.
- Completed
- Registry status
- 12
- Enrollment target
NCT00763152: Completed study, sponsored by Varian, a Siemens Healthineers Company.
NCT00763152 is a clinical trial that has completed, run by Varian, a Siemens Healthineers Company. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00763152 has completed, sponsored by Varian, a Siemens Healthineers Company.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This is an observational study to collect placement and tracking data for patients who have the Calypso transponders implanted into the peri-prostatic tissue.
Interventions
- OTHER Observation of transponder stability
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-09 |
| Est. Completion | 2009-08 |
What the finished NCT00763152 record still lists
NCT00763152 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observation of transponder stability is the first listed.
NCT00763152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00763152 about?
NCT00763152 is a clinical study titled "CMT-07-08: The PROstate Bed Evaluation Study". This is an observational study to collect placement and tracking data for patients who have the Calypso transponders implanted into the peri-prostatic tissue.
What is the current status of trial NCT00763152?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2008-09. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00763152?
The interventions under investigation include: Observation of transponder stability (OTHER).
Who is sponsoring clinical trial NCT00763152?
This trial is sponsored by Varian, a Siemens Healthineers Company, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia